Feasibility and Safety of Ketamine for Suicidal Patients in the Emergency Department
Feasibility and Safety of Single Dose Ketamine for Acutely Suicidal Patients in the Emergency Department
Lindsay Maguire, MD
50 participants
May 1, 2024
INTERVENTIONAL
Conditions
Summary
There is currently no readily available pharmacologic intervention for suicidal ideation, a true psychiatric emergency, in the Emergency Department (ED). Investigators aim to trial low-dose, intravenous ketamine, a drug with well-established use in treatment-resistant depression, for patients who present to the ED with suicidal ideation.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Patients will receive 0.2mg/kg of IV ketamine
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06085937